Anavex Life Sciences Corp
Biotechnology
Healthcare
AVXL
85.07 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
8.69
52 week high
13.46
high
8.88
52 week low
0.00
low
8.48
growth
50.89 %
previous Close
8.74
P/E ratio
market cap
937 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top